ESMO Congress Round-Up With Dr. Evan Yu: PSMAfore

In the second part of this ESMO Congress round-up video series, Evan Yu, MD, of the Fred Hutchinson Cancer Center, gives a background on the clinical trial successes of Lu-177 PSMA-617 to date.

He also comments on how the data from the PSMAfore study add to our existing understanding of the therapy.

View Dr. Yu’s further thoughts on EV-302 and CheckMate 901, as well as LITESPARK-005.